- Barrons.com•17 hours ago
Specialty pharmaceutical companies--think Allergan (AGN), Shire (SHPG), Valeant Pharmaceuticals International (VRX), Teva Pharmaceutical Industries (TEVA), and Endo International (ENDP), among others--have ...
- Market Realist•4 days ago
Vertex Pharmaceuticals (VRTX) will report its 2Q16 earnings on July 27, 2016. Based in Boston, VRTX is a global biotechnology company that primarily focuses on cystic fibrosis drugs.
After hours: 194.532.24 (1.16%) as of 5:16 PM EDT
|Bid||184.90 x 100|
|Ask||250.10 x 100|
|52wk Range||147.60 - 270.63|
|Day's Range||190.79 - 193.27|
|Avg Vol (3m)||2,875,544|
As of 4:00 PM EDT. Market closed.